domperidone has been researched along with Anochlesia in 7 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The intensity of DOM-induced catalepsy was significantly potentiated by the coadministration of CsA." | 1.32 | Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A. ( Dan, Y; Iga, T; Murakami, H; Nogawa, K; Ohtani, H; Sato, H; Sawada, Y; Tsujikawa, K; Yamada, Y, 2003) |
| "The emetic and catalepsy-inducing actions of buflomedil were studied in dog and mice." | 1.27 | [Emetic and catalepsy-inducing actions of buflomedil]. ( Hashimoto, T; Koda, H; Kuriyama, K, 1988) |
| "The chronic administration of haloperidol (HAL), domperidone (DOM), or sulpiride (SUL) increased the density of striatal dopamine (DA) receptors in intact but not in hypophysectomized (Hypox) male rats." | 1.27 | Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonists. ( Hruska, RE, 1986) |
| "Prior to the induction of catalepsy and after recovery from it, mice display the entire range of typical apomorphine-induced behavior including sniffing, climbing, gnawing, and licking." | 1.27 | Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice. ( Randall, PK; Yurek, DM, 1985) |
| "Domperidone induced a weak catalepsy in decompressed rats, but failed to induce any catalepsy in control rats." | 1.26 | Changes in blood-brain barrier permeability to drugs in decompressed rats. ( Kaakkola, S; Laitinen, LA; Lehtosalo, J, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monković, I | 1 |
| Willner, D | 1 |
| Adam, MA | 1 |
| Brown, M | 1 |
| Crenshaw, RR | 1 |
| Fuller, CE | 1 |
| Juby, PF | 1 |
| Luke, GM | 1 |
| Matiskella, JA | 1 |
| Montzka, TA | 1 |
| Koener, B | 1 |
| Goursaud, S | 1 |
| Van De Stadt, M | 1 |
| Calas, AG | 1 |
| Jeanjean, AP | 1 |
| Maloteaux, JM | 1 |
| Hermans, E | 1 |
| Tsujikawa, K | 1 |
| Dan, Y | 1 |
| Nogawa, K | 1 |
| Sato, H | 1 |
| Yamada, Y | 1 |
| Murakami, H | 1 |
| Ohtani, H | 1 |
| Sawada, Y | 1 |
| Iga, T | 1 |
| Kaakkola, S | 1 |
| Lehtosalo, J | 1 |
| Laitinen, LA | 1 |
| Koda, H | 1 |
| Hashimoto, T | 1 |
| Kuriyama, K | 1 |
| Hruska, RE | 1 |
| Yurek, DM | 1 |
| Randall, PK | 1 |
7 other studies available for domperidone and Anochlesia
| Article | Year |
|---|---|
Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesis.
Topics: Animals; Antiemetics; Benzamides; Catalepsy; Chemical Phenomena; Chemistry; Cisplatin; Dogs; Dopamin | 1988 |
Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.
Topics: Animals; Apomorphine; Aripiprazole; Buffers; Catalepsy; Cell Membrane; Cerebral Cortex; Corpus Stria | 2011 |
Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Catalepsy; Cyclosporine; Domperido | 2003 |
Changes in blood-brain barrier permeability to drugs in decompressed rats.
Topics: Animals; Atropine; Atropine Derivatives; Blood-Brain Barrier; Catalepsy; Decompression Sickness; Dom | 1982 |
[Emetic and catalepsy-inducing actions of buflomedil].
Topics: Administration, Oral; Animals; Bromocriptine; Catalepsy; Dogs; Domperidone; Dose-Response Relationsh | 1988 |
Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonists.
Topics: Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Domperidone; Haloperidol; Male; Prolactin; Ra | 1986 |
Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice.
Topics: Animals; Apomorphine; Catalepsy; Chlorpromazine; Domperidone; Drug Interactions; Haloperidol; Inject | 1985 |